Skip to main content
. 2021 Nov 24;12:752233. doi: 10.3389/fimmu.2021.752233

Figure 1.

Figure 1

SARS-CoV2 IgG and neutralizing antibodies in individuals stratified by diabetes (A, B), obesity levels (C, D), hypertension (E, F), and gender (G, H). All individuals took two doses of BNT162b2 (Pfizer–BioNTech) vaccine, and this was plotted with days since vaccination shown based on the color intensity.